Chemoembolization in patients with hepatocellular carcinoma.
about
Therapeutic Strategies in HCC: Radiation ModalitiesHepatobiliary Tumors: Update on Diagnosis and ManagementManagement of Hepatocellular Carcinoma in Cirrhotic Patients with Portal Hypertension: Relevance of Hagen-Poiseuille's LawMultimodality Management for Barcelona Clinic Liver Cancer Stage C Hepatocellular CarcinomaTransarterial radioembolization using yttrium-90 microspheres in the treatment of hepatocellular carcinoma: a review on clinical utility and developmentsDrug therapy for advanced-stage liver cancerClinical trials of combined molecular targeted therapy and locoregional therapy in hepatocellular carcinoma: past, present, and futureRadioembolization with Yttrium-90 microspheres in hepatocellular carcinoma: Role and perspectivesYttrium-90 microspheres: a review of its emerging clinical indicationsPhase I/II Study of Sorafenib in Combination with Hepatic Arterial Infusion Chemotherapy Using Low-Dose Cisplatin and 5-FluorouracilTACE performed in patients with a single nodule of hepatocellular carcinoma.Effectiveness of Sorafenib in Patients with Transcatheter Arterial Chemoembolization (TACE) Refractory and Intermediate-Stage Hepatocellular Carcinoma.Predictive biomarkers of antiangiogenic therapy for advanced hepatocellular carcinoma: where are we?Surgical strategy for liver cancers in the era of effective chemotherapy.Tracking Navigation Imaging of Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma Using Three-Dimensional Cone-Beam CT Angiography.Radiotherapeutic options for hepatocellular carcinoma with portal vein tumor thrombosisAssessment of hepatic function with Gd-EOB-DTPA-enhanced hepatic MRI.Yttrium-90 radioembolization for hepatocellular carcinoma: what we know and what we need to know.Therapeutic response assessment of transcatheter arterial chemoembolization for hepatocellular carcinoma: ultrasonography, CT and MR imaging.Treatment of advanced hepatocellular carcinoma with emphasis on hepatic arterial infusion chemotherapy and molecular targeted therapy.How to define transarterial chemoembolization failure or refractoriness: a European perspectiveSurgical and Locoregional Therapy of HCC: TACE.The Clinical Impact of Transcatheter Arterial Chemoembolization (TACE)-Induced c-Met Upregulation on TACE Refractoriness in Hepatocellular Carcinoma.Target lesion response predicts survival of patients with hepatocellular carcinoma retreated with transarterial chemoembolization.Sorafenib after resection improves the outcome of BCLC stage C hepatocellular carcinoma.Transarterial chemoembolization for huge hepatocellular carcinoma with diameter over ten centimeters: a large cohort study.Survival Benefit of Locoregional Treatment for Hepatocellular Carcinoma with Advanced Liver CirrhosisWhy does every hepatocellular carcinoma clinical trial using molecular targeted agents fail?Transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: recent progression and perspective.Transcatheter arterial chemoembolization combined with radiofrequency ablation for the treatment of hepatocellular carcinoma.Real-life clinical practice with sorafenib in advanced hepatocellular carcinoma: a single-center experience.How to improve treatment outcomes for hepatocellular carcinoma of intermediate and advanced stage.Patient Selection for Transarterial Chemoembolization in Hepatocellular Carcinoma: Importance of Benefit/Risk Assessment.GALNT14 genotype effectively predicts the therapeutic response in unresectable hepatocellular carcinoma treated with transcatheter arterial chemoembolization.Imbalance in systemic inflammation and immune response following transarterial chemoembolization potentially increases metastatic risk in huge hepatocellular carcinoma.Quantification of tumor DNA in serum and vascular invasion of human hepatocellular carcinoma.Image quality of arterial phase and parenchymal blood volume (PBV) maps derived from C-arm computed tomography in the evaluation of transarterial chemoembolization.Dynamic changes of the inflammation-based index predict mortality following chemoembolisation for hepatocellular carcinoma: a prospective studyTranscatheter arterial chemoembolization monotherapy vs combined transcatheter arterial chemoembolization–percutaneous microwave coagulation therapy for massive hepatocellular carcinoma (≥10 cm)
P2860
Q26738658-3E71FA5F-27A8-4A23-B5F3-6793C4506821Q26775654-CB328BE2-50C2-4F10-9DD6-99E49D6EE9F0Q26797581-CC950EF8-1C2A-4517-9154-D61C61E8C7B0Q26797643-82E11C04-9A91-4167-BA9D-3F89755EFC5BQ26852174-F5F16361-A51F-4E46-91A7-9B24AD8C3ED7Q27004410-5305DABE-D849-4B2A-8BCD-305899B978E7Q27013055-C1603DF1-9644-495A-A303-25D0021E1733Q27023616-6D8DF9FE-E405-45A6-9746-0A616A4AE180Q28083856-FFA7BB00-AC9B-4A31-A897-4F621B3A4179Q33428936-F37D1477-B3A8-46AF-BC5C-97819CEE0F64Q34136129-8D26707D-848C-4509-8456-4B8EB917DE92Q36423170-CCB3089E-BEA7-486A-88E2-CAE4FFD8CD93Q37088265-1164B208-5DF2-46AC-9D91-45400763C4E9Q37105519-3CA54CBC-3C37-400C-940E-8BC1F6AFB5F8Q37716190-8CAF971F-AFEE-41EA-B67F-286FC5827DC1Q37716214-F17C4264-5D40-463E-B26D-1C983CE0913AQ38069066-7002BA0F-395E-4AF9-9389-F12370D5A2BEQ38083431-DBC9E079-2085-413F-ADDB-4C711EDFDEB4Q38083432-5D80622B-3DBC-4B63-8B95-22FB7DA7630EQ38155506-A1787AD1-577A-4D98-9707-528DA92CA365Q38221512-618D3B74-6DE8-46F3-A3AC-EA8F3DCB7436Q38671236-CCE1B09D-11AF-48AC-A126-ADC18498A9AAQ38806970-D5DA3463-735F-452C-9A7F-BD8342DBAE9AQ39830114-3E27454A-405C-4E38-8548-9A9F87692890Q39929763-EB8D59B1-CD57-4842-8FBA-FF039056790DQ41435420-0642EA45-6269-4C03-80FA-2BA9541BABECQ41864202-065DB03F-BCE4-4940-94C0-75AD03B44BC5Q42560671-3CF39148-D7B5-4794-B07D-6C94336BE055Q44697301-90205D4D-07B5-4D08-A207-D94EBA91E5B8Q45728871-142E7803-EB4D-408C-97B1-B5224D631F31Q51285944-035EA9D0-5785-4006-9761-28FD9742D5BEQ51842347-154A1191-5328-41E8-95D9-9EEC21673AEBQ52584231-7D1AA4A6-3EA4-413B-AD1A-F7CF77589E7BQ53178946-BE61212C-3844-4ABE-8047-C52DA10DCD14Q53218066-E366674E-E5E2-40F5-B292-C28C53E25CE2Q54270867-95E8AF51-3841-4A2E-B5C2-F9C38F59C7E5Q55423767-7D047CC7-DF9B-4ABE-97CE-878EDCBEA615Q57762765-EBB136D7-18CE-4C5B-84F0-8F106AA30B02Q59135179-28A879FE-2D3A-4C30-8FD7-52F2FEAA96BF
P2860
Chemoembolization in patients with hepatocellular carcinoma.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Chemoembolization in patients with hepatocellular carcinoma.
@en
type
label
Chemoembolization in patients with hepatocellular carcinoma.
@en
prefLabel
Chemoembolization in patients with hepatocellular carcinoma.
@en
P2860
P356
P1433
P1476
Chemoembolization in patients with hepatocellular carcinoma.
@en
P2093
Riccardo Lencioni
P2860
P356
10.1159/000339019
P577
2012-06-01T00:00:00Z